Status:
RECRUITING
Virtual Reality for Pain Management During Dupilumab Injection
Lead Sponsor:
St. Justine's Hospital
Conditions:
Atopic Dermatitis
Pain
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
The aim of this within-subject randomized study is to examine the efficacy of a VR immersive game for pain and anxiety management of children during the subcutaneous injection of dupilumab for moderat...
Detailed Description
Background : Atopic dermatitis is one of the most common inflammatory diseases of the skin and usually starts in early childhood.The prevalence of atopic dermatitis ranges from 15 to 20% among childr...
Eligibility Criteria
Inclusion
- between the ages of 6 to 17 years old,
- suffering from moderate to severe atopic dermatitis and receiving or about to start subcutaneous injections of dupilumab,
- in the presence of a consenting parent who can understand, read, and write either French or English.
Exclusion
- have a diagnosed cognitive impairment precluding them from playing a virtual reality game,
- suffer from epilepsy considering the nature of the intervention,
- cannot be in a sitting position during the procedure as the virtual reality game requires an angle of at least 30 degrees for head-tracking.
Key Trial Info
Start Date :
May 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT06182436
Start Date
May 16 2024
End Date
January 1 2028
Last Update
August 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Justine's Hospital
Montreal, Quebec, Canada, H1T 3C5
2
CHU Sainte-Justine
Montreal, Quebec, Canada, H3T 1C5